Tinea Capitis: Current Concepts in Clinical Practice

Total Page:16

File Type:pdf, Size:1020Kb

Tinea Capitis: Current Concepts in Clinical Practice CONTINUING MEDICAL EDUCATION Tinea Capitis: Current Concepts in Clinical Practice Matthew J. Trovato, MD; Robert A. Schwartz, MD, MPH; Camila K. Janniger, MD GOAL To understand tinea capitis to better treat patients with the condition OBJECTIVES Upon completion of this activity, dermatologists and general practitioners should be able to: 1. Describe the etiology of tinea capitis. 2. Recognize and diagnose tinea capitis. 3. Effectively treat tinea capitis. CME Test on page 88. This article has been peer reviewed and is accredited by the ACCME to provide continuing approved by Victor B. Hatcher, PhD, Professor of medical education for physicians. Medicine, Albert Einstein College of Medicine. Albert Einstein College of Medicine designates Review date: January 2006. this educational activity for a maximum of 1 This activity has been planned and implemented category 1 credit toward the AMA Physician’s in accordance with the Essential Areas and Policies Recognition Award. Each physician should of the Accreditation Council for Continuing Medical claim only that credit that he/she actually spent Education through the joint sponsorship of Albert in the activity. Einstein College of Medicine and Quadrant This activity has been planned and produced in HealthCom, Inc. Albert Einstein College of Medicine accordance with ACCME Essentials. Drs. Trovato, Schwartz, and Janniger report no conflict of interest. The authors discuss off-label use of fluconazole, itraconazole, ketoconazole, and terbinafine. Dr. Hatcher reports no conflict of interest. Tinea capitis is a common infection, particularly seen in Europe and many other countries, which among young children in urban regions. The emit a green fluorescence. However, T tonsurans, infection often is seen in a form with mild scaling like other fungi, also may less often produce an and little hair loss, a result of the prominence of intense inflammatory reaction, which is sugges- Trichophyton tonsurans (the most frequent cause tive of an acute bacterial infection. of tinea capitis in the United States). T tonsurans Cutis. 2006;77:93-99. does not fluoresce under Wood light, unlike the common tinea capitis–causing fungal organisms inea capitis, or ringworm of the scalp, is most Accepted for publication September 9, 2005. common in preschool and school-age children From Dermatology and Pediatrics, UMDNJ-New Jersey T and often is associated with crowded living Medical School, Newark. Dr. Trovato is a plastic surgery resident, conditions.1-5 In the United States, Trichophyton Dr. Schwartz is Professor and Head of Dermatology, and tonsurans causes most cases of tinea capitis and Dr. Janniger is Clinical Professor and Chief of Pediatric Dermatology. Reprints: Camila K. Janniger, MD, Pediatric Dermatology, at times produces widespread scaling with minimal New Jersey Medical School, 185 S Orange Ave, Newark, NJ hair loss, prompting suspicion of seborrheic derma- 07103-2714 (e-mail: [email protected]). titis. T tonsurans also may induce violent tissue VOLUME 77, FEBRUARY 2006 93 Tinea Capitis reactions, including inflammation and pustulation, species of dermatophyte are capable of producing which is suggestive of an acute bacterial infection.2 tinea capitis, some species have a greater tendency Alternatively, childhood infections with this fungus than others, and a few (namely Epidermophyton may be asymptomatic. A central European study floccosum) are noted for no involvement of the scalp showed a peak incidence of scalp fungal infections hair. When molds other than the 3 dermatophytic in children aged 4 to 6 years.5 Another survey con- fungi described above attack the hair, nails, or skin, ducted in an urban pediatric clinic in the United infection by these nondermatophytic fungi is called States reported an overall incidence of scalp fungal dermatomycosis rather than dermatophytosis. infections of 4%, with the highest incidence, 12.7%, Tinea capitis is characterized by broken hair occurring among black girls.1 This higher incidence and often produces alopecia (Figure). Previously, was thought to be related to the use of occlusive Microsporum audouinii and Microsporum canis were pomades and tight braiding of the girls’ hair. How- the most common causes of tinea capitis in pre- ever, a race-matched case-controlled study showed pubescent children because of the children’s contact that use of oils or grease, hairstyling, frequency of with cats and dogs.17 M audouinii and M canis emit washing, and other hair care practices were not asso- a green fluorescence under a Wood light; however, ciated with the presence of tinea capitis.6 The pres- nonfluorescent T tonsurans has replaced these ence of an adult carrier state in juvenile tinea capitis 2 organisms as the most common cause of tinea warrants a thorough evaluation of the patient’s capitis in North America.8-13 This development immediate and extended families.2 may be due to shifting immigration patterns from Mexico, Central America, and South America.18 In Etiology Africa, Pakistan/India, South America, and eastern Tinea capitis is caused by dermatophytic infections Europe, the most common cause of tinea capitis is that belong to 3 genera of fungi: Trichophyton, Trichophyton violaceum, whereas in western Europe, Microsporum, and Epidermophyton.5-16 Ecologically, it is M canis,5,8 with cats serving as a common vec- these fungi can be classified by host preference as tor.13 Trichophyton soudanense is a significant cause either anthropophilic (humans), geophilic (soil), or of tinea capitis in Africa but is a rare cause else- zoophilic (animals). Clinically, the patterns of infec- where in the world. M audouinii often produces a tion of these fungi are classified by anatomic prefer- noninflammatory infection that is almost asymp- ence, such as tinea capitis (scalp), tinea pedis (foot), tomatic. At the other end of the spectrum, a severe, or tinea corporis (body). These fungi characteristi- inflammatory kerion may be produced that is most cally produce infections with an active circinate often because of either T tonsurans or M canis. margin, hence the term ringworm. Although most Another severe, inflammatory type of tinea capitis, Tinea capitis displaying a patchy alopecia with some evidence of matting, which is suggestive of kerion development. 94 CUTIS® Tinea Capitis called favus, is due to Trichophyton schoenleinii.15 at the site of the broken hairs. The alopecia charac- Granulomatous perifolliculitis also may be seen, teristically is asymptomatic without evidence of scar- usually due to Trichophyton rubrum, manifesting on ring, atrophy, or erythema. T tonsurans often produces shaved legs rather than on the scalp. dry, seborrheic dermatitis–like scaling without When hair is involved, fungal infections are inflammation and with only slight loss of scalp hair.13 divided into 2 types: ectothrix (M audouinii, This virtually asymptomatic infection may persist M canis), whereby spores are present on the hair sur- throughout childhood. However, a more serious face only, and endothrix (T tonsurans, T violaceum, reaction may occur, with the formation of black-dot T soudanense), whereby spores are present within stubs in areas of marked alopecia. Pruritus with the hair follicle; endothrix infection spores also are lichenification and secondary excoriation may occur present on the skin surface, hence the ability to per- in some patients. The pruritus is thought to be psy- form a fungal culture of this infection. Fungi enter chogenic in nature.19 Other patients experience a the proximal cortex where the cuticle is immature; severe inflammatory reaction. the fungi then colonize the proximal keratinized The 2 severe types of tinea capitis are kerion and cortex and generate septate hyphae that become favus. A kerion is a painfully inflamed, crusty, mat- arthrospores and replace the cortex; this may cause ted mass that often is associated with purulent the weakened hair to coil up inside the infundibu- drainage from the sinuses. Regional lymphadenopa- lum and form the black dots of black dot ringworm. thy is characteristic.20,21 Kerions tend to be small T rubrum rarely affects the hair shaft; nevertheless, and solitary, though multiple plaques or one giant when it does, the infection may be both nonfluores- mass involving most of the scalp may be seen. Favus cent ectothrix and endothrix.11,16 produces inflammation and scarring, and is charac- terized by yellow cup-shaped crusts called scutula Historical Considerations that are found around a hair.15 These crusts contain In Rome around 30 AD, an acute inflammatory infectious hyphal masses that coalesce into a yellow scalp condition with purulent drainage was first hyperkeratotic mass. described by Celsus; thus, the kerion is some times referred to as kerion celsi.11,14 During the turn of Laboratory Characteristics the 20th century, tinea capitis was a plague.14 A 10% potassium hydroxide preparation of skin Accordingly, Europeans attempting to immigrate scrapings provides an adequate cytologic specimen to America who had tinea capitis, especially the for examination and diagnosis. Smearing the speci- favus type, were barred at Ellis Island. The history men on a glass slide using a scalpel blade or the of this infection has had a predictable effect on its edge of the slide, and then applying the 10% potas- epidemiology in the United States, which differs sium hydroxide, yields consistent diagnostic from that in Europe. M audouinii was responsible results.22 Results of microscopic examinations for causing most tinea
Recommended publications
  • Fungal Infections from Human and Animal Contact
    Journal of Patient-Centered Research and Reviews Volume 4 Issue 2 Article 4 4-25-2017 Fungal Infections From Human and Animal Contact Dennis J. Baumgardner Follow this and additional works at: https://aurora.org/jpcrr Part of the Bacterial Infections and Mycoses Commons, Infectious Disease Commons, and the Skin and Connective Tissue Diseases Commons Recommended Citation Baumgardner DJ. Fungal infections from human and animal contact. J Patient Cent Res Rev. 2017;4:78-89. doi: 10.17294/2330-0698.1418 Published quarterly by Midwest-based health system Advocate Aurora Health and indexed in PubMed Central, the Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes, and the patient experience. REVIEW Fungal Infections From Human and Animal Contact Dennis J. Baumgardner, MD Aurora University of Wisconsin Medical Group, Aurora Health Care, Milwaukee, WI; Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI; Center for Urban Population Health, Milwaukee, WI Abstract Fungal infections in humans resulting from human or animal contact are relatively uncommon, but they include a significant proportion of dermatophyte infections. Some of the most commonly encountered diseases of the integument are dermatomycoses. Human or animal contact may be the source of all types of tinea infections, occasional candidal infections, and some other types of superficial or deep fungal infections. This narrative review focuses on the epidemiology, clinical features, diagnosis and treatment of anthropophilic dermatophyte infections primarily found in North America.
    [Show full text]
  • Serious Fungal Infections in Peru
    Eur J Clin Microbiol Infect Dis DOI 10.1007/s10096-017-2924-9 ORIGINAL ARTICLE Serious fungal infections in Peru B. Bustamante1 & D. W. Denning2 & P. E. Campos3 Received: 21 December 2016 /Accepted: 21 December 2016 # Springer-Verlag Berlin Heidelberg 2017 Abstract Epidemiological data about mycotic diseases are This first attempt to assess the fungal burden in Peru needs limited in Peru and estimation of the fungal burden has not to be refined. We believe the figure obtained is an underesti- been previously attempted. Data were obtained from the mation, because of under diagnosis, non-mandatory reporting Peruvian National Institute of Statistics and Informatics, and lack of a surveillance system and of good data about the UNAIDS and from the Ministry of Health’s publications. size of populations at risk. We also searched the bibliography for Peruvian data on my- cotic diseases, asthma, COPD, cancer and transplants. Incidence or prevalence for each fungal disease were estimat- Introduction ed in specific populations at risk. The Peruvian population for 2015 was 31,151,543. In 2014, the estimated number of HIV/ While candidemia and invasive aspergillosis (IA) are clearly AIDS and pulmonary tuberculosis cases was 88,625, 38,581 recognized as important causes of morbidity and mortality, of them not on ART, and 22,027, respectively. A total of other mycotic agents or different clinical presentations are im- 581,174 cases of fungal diseases were estimated, representing portant in specific regions. Socio-economic and geo- approximately 1.9% of the Peruvian population. This figure ecological characteristics and size of susceptible populations includes 498,606, 17,361 and 4,431 vulvovaginal, oral and are the main determinants of variations on incidence of fungal esophageal candidiasis, respectively, 1,557 candidemia cases, infections across the world.
    [Show full text]
  • Estimated Burden of Fungal Infections in Oman
    Journal of Fungi Article Estimated Burden of Fungal Infections in Oman Abdullah M. S. Al-Hatmi 1,2,3,* , Mohammed A. Al-Shuhoumi 4 and David W. Denning 5 1 Department of microbiology, Natural & Medical Sciences Research Center, University of Nizwa, Nizwa 616, Oman 2 Department of microbiology, Centre of Expertise in Mycology Radboudumc/CWZ, 6500 Nijmegen, The Netherlands 3 Foundation of Atlas of Clinical Fungi, 1214GP Hilversum, The Netherlands 4 Ibri Hospital, Ministry of Health, Ibri 115, Oman; [email protected] 5 Manchester Fungal Infection Group, Manchester Academic Health Science Centre, The University of Manchester, Manchester M13 9PL, UK; [email protected] * Correspondence: [email protected]; Tel.: +968-25446328; Fax: +968-25446612 Abstract: For many years, fungi have emerged as significant and frequent opportunistic pathogens and nosocomial infections in many different populations at risk. Fungal infections include disease that varies from superficial to disseminated infections which are often fatal. No fungal disease is reportable in Oman. Many cases are admitted with underlying pathology, and fungal infection is often not documented. The burden of fungal infections in Oman is still unknown. Using disease frequencies from heterogeneous and robust data sources, we provide an estimation of the incidence and prevalence of Oman’s fungal diseases. An estimated 79,520 people in Oman are affected by a serious fungal infection each year, 1.7% of the population, not including fungal skin infections, chronic fungal rhinosinusitis or otitis externa. These figures are dominated by vaginal candidiasis, followed by allergic respiratory disease (fungal asthma). An estimated 244 patients develop invasive aspergillosis and at least 230 candidemia annually (5.4 and 5.0 per 100,000).
    [Show full text]
  • Introduction to Bacteriology and Bacterial Structure/Function
    INTRODUCTION TO BACTERIOLOGY AND BACTERIAL STRUCTURE/FUNCTION LEARNING OBJECTIVES To describe historical landmarks of medical microbiology To describe Koch’s Postulates To describe the characteristic structures and chemical nature of cellular constituents that distinguish eukaryotic and prokaryotic cells To describe chemical, structural, and functional components of the bacterial cytoplasmic and outer membranes, cell wall and surface appendages To name the general structures, and polymers that make up bacterial cell walls To explain the differences between gram negative and gram positive cells To describe the chemical composition, function and serological classification as H antigen of bacterial flagella and how they differ from flagella of eucaryotic cells To describe the chemical composition and function of pili To explain the unique chemical composition of bacterial spores To list medically relevant bacteria that form spores To explain the function of spores in terms of chemical and heat resistance To describe characteristics of different types of membrane transport To describe the exact cellular location and serological classification as O antigen of Lipopolysaccharide (LPS) To explain how the structure of LPS confers antigenic specificity and toxicity To describe the exact cellular location of Lipid A To explain the term endotoxin in terms of its chemical composition and location in bacterial cells INTRODUCTION TO BACTERIOLOGY 1. Two main threads in the history of bacteriology: 1) the natural history of bacteria and 2) the contagious nature of infectious diseases, were united in the latter half of the 19th century. During that period many of the bacteria that cause human disease were identified and characterized. 2. Individual bacteria were first observed microscopically by Antony van Leeuwenhoek at the end of the 17th century.
    [Show full text]
  • Boards' Fodder
    boards’ fodder Medical Mycology By Adriana Schmidt, MD, and Natalie M. Curcio, MD, MPH. (Updated July 2015*) SUPERFICIAL ORGANISM CLINICAL HISTO/KOH TREATMENT MYCOSES* Pityriasis Malessezia furfur Hypo- or hyper-pigmented Spaghetti & meatballs: Antifungal shampoos and/or versicolor macules short hyphae + yeast PO therapy Tinea nigra Hortaea werneckii (formerly Brown-black non-scaly Branching septate hyphae Topical imidazoles or palmaris Phaeoannellomyces werneckii) macules + budding yeast allylamines Black piedra Piedraia hortae Hard firm black Dark hyphae around concretions acrospores Cut hair off, PO terbinafine, White piedra Trichosporon ovoides or inkin Soft loose white Blastoconidia, imidazoles, or triazoles (formely beigelii) concretions arthroconidia Fluorescent small Microsporum Canis KOH: spores on outside spore ectothrix: M. audouinii of the hair shaft; “Cats And Dogs M. distortum Wood’s lamp --> yellow Sometimes Fight T. schoenleinii fluorescence & Growl” M. ferrugineum+/- gypseum Large spore Trichophyton spp. (T. tonsurans in North America; T. violaceum in KOH: spores within hair Topical antifungals; PO endothrix Europe, Asia, parts of Africa). shaft antifungals for T. manuum, Tinea corporis T. rubrum > T. mentag. Majocchi’s granuloma: T. rubrum capitis, unguium T. pedis Moccasin: T. rubrum, E. floccosum. Interdigital/vesicular: T. mentag T. unguium Distal lateral, proximal and proximal white subungual: T. rubrum. White superficial: T. mentag. HIV: T. rubrum SUBQ MYCOSES** ORGANISM TRANSMISSION CLINICAL HISTO/KOH TREATMENT
    [Show full text]
  • Oral Antifungals Month/Year of Review: July 2015 Date of Last
    © Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 | Fax 503-947-1119 Class Update with New Drug Evaluation: Oral Antifungals Month/Year of Review: July 2015 Date of Last Review: March 2013 New Drug: isavuconazole (a.k.a. isavunconazonium sulfate) Brand Name (Manufacturer): Cresemba™ (Astellas Pharma US, Inc.) Current Status of PDL Class: See Appendix 1. Dossier Received: Yes1 Research Questions: Is there any new evidence of effectiveness or safety for oral antifungals since the last review that would change current PDL or prior authorization recommendations? Is there evidence of superior clinical cure rates or morbidity rates for invasive aspergillosis and invasive mucormycosis for isavuconazole over currently available oral antifungals? Is there evidence of superior safety or tolerability of isavuconazole over currently available oral antifungals? • Is there evidence of superior effectiveness or safety of isavuconazole for invasive aspergillosis and invasive mucormycosis in specific subpopulations? Conclusions: There is low level evidence that griseofulvin has lower mycological cure rates and higher relapse rates than terbinafine and itraconazole for adult 1 onychomycosis.2 There is high level evidence that terbinafine has more complete cure rates than itraconazole (55% vs. 26%) for adult onychomycosis caused by dermatophyte with similar discontinuation rates for both drugs.2 There is low
    [Show full text]
  • Tinea Capitis 2014 L.C
    BJD GUIDELINES British Journal of Dermatology British Association of Dermatologists’ guidelines for the management of tinea capitis 2014 L.C. Fuller,1 R.C. Barton,2 M.F. Mohd Mustapa,3 L.E. Proudfoot,4 S.P. Punjabi5 and E.M. Higgins6 1Department of Dermatology, Chelsea & Westminster Hospital, Fulham Road, London SW10 9NH, U.K. 2Department of Microbiology, Leeds General Infirmary, Leeds LS1 3EX, U.K. 3British Association of Dermatologists, Willan House, 4 Fitzroy Square, London W1T 5HQ, U.K. 4St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust, St Thomas’ Hospital, Westminster Bridge Road, London SE1 7EH, U.K. 5Department of Dermatology, Hammersmith Hospital, 150 Du Cane Road, London W12 0HS, U.K. 6Department of Dermatology, King’s College Hospital, Denmark Hill, London SE5 9RS, U.K. 1.0 Purpose and scope Correspondence Claire Fuller. The overall objective of this guideline is to provide up-to- E-mail: [email protected] date, evidence-based recommendations for the management of tinea capitis. This document aims to update and expand Accepted for publication on the previous guidelines by (i) offering an appraisal of 8 June 2014 all relevant literature since January 1999, focusing on any key developments; (ii) addressing important, practical clini- Funding sources cal questions relating to the primary guideline objective, i.e. None. accurate diagnosis and identification of cases; suitable treat- ment to minimize duration of disease, discomfort and scar- Conflicts of interest ring; and limiting spread among other members of the L.C.F. has received sponsorship to attend conferences from Almirall, Janssen and LEO Pharma (nonspecific); has acted as a consultant for Alliance Pharma (nonspe- community; (iii) providing guideline recommendations and, cific); and has legal representation for L’Oreal U.K.
    [Show full text]
  • Therapies for Common Cutaneous Fungal Infections
    MedicineToday 2014; 15(6): 35-47 PEER REVIEWED FEATURE 2 CPD POINTS Therapies for common cutaneous fungal infections KENG-EE THAI MB BS(Hons), BMedSci(Hons), FACD Key points A practical approach to the diagnosis and treatment of common fungal • Fungal infection should infections of the skin and hair is provided. Topical antifungal therapies always be in the differential are effective and usually used as first-line therapy, with oral antifungals diagnosis of any scaly rash. being saved for recalcitrant infections. Treatment should be for several • Topical antifungal agents are typically adequate treatment weeks at least. for simple tinea. • Oral antifungal therapy may inea and yeast infections are among the dermatophytoses (tinea) and yeast infections be required for extensive most common diagnoses found in general and their differential diagnoses and treatments disease, fungal folliculitis and practice and dermatology. Although are then discussed (Table). tinea involving the face, hair- antifungal therapies are effective in these bearing areas, palms and T infections, an accurate diagnosis is required to ANTIFUNGAL THERAPIES soles. avoid misuse of these or other topical agents. Topical antifungal preparations are the most • Tinea should be suspected if Furthermore, subsequent active prevention is commonly prescribed agents for dermatomy- there is unilateral hand just as important as the initial treatment of the coses, with systemic agents being used for dermatitis and rash on both fungal infection. complex, widespread tinea or when topical agents feet – ‘one hand and two feet’ This article provides a practical approach fail for tinea or yeast infections. The pharmacol- involvement. to antifungal therapy for common fungal infec- ogy of the systemic agents is discussed first here.
    [Show full text]
  • Subcutaneous Mass Aspiration Between the Digits of an 8 Month Old English Bulldog Marked Inflammation: Neutrophils & Macrophages
    Subcutaneous mass aspiration between the digits of an 8 month old English Bulldog Marked inflammation: neutrophils & macrophages Hair fragment Macrophages What is this structure? Degenerate Neutrophils Abundant amount of keratin with similar structures The structures are ~ 2‐3 micron in size, blue to occasionally dark purple, oval to round in shape and have a thin clear capsule, consistent with fungal organisms The fungi are seen also in neutrophils and free in the background Growth of Microsporum canis was diagnosed on fungal culture • Microsporum canis is a dermatophyte that frequently causes infection of the superficial layers of skin, hair and nails (dermtophytoses). 1,2 • Microsporum canis, Microsporum gypseum and Trichophyton mentagrophytes are the main etiologic agents of clinical dermatophytosis. 3 • Dermatophytes affect the hair shafts, stratum corneum and nails or claws of animals and people. 2 • The typical lesions include focal alopecia, broken hair shafts, crusts scales and erythema on the head, feet and tail of dogs and cats. 1 • The structures seen in this cytology were Microsporum arthroconidia, which should be differentiated from other similar fungal yeast bodies seen in Candidiasis, Histoplasmosis, Aspergillosis/Penicillosis and Sporotrichosis. 2,4 Kerion • Less commonly dermatophytosis causes raised or dermal nodules called kerions or nodular dermatophytosis. 1,3 • These lesions are formed when the infected hair follicle ruptures and both the fungi and keratin spill in the dermis eliciting an intense inflammatory response. 1 • This may develop in any species but is most commonly reported in dogs. 3 • M. canis is the most common cause of kerion in dogs. 3 • Most common locations were the head, neck and limbs.
    [Show full text]
  • Mucormycosis: a Review on Environmental Fungal Spores and Seasonal Variation of Human Disease
    Advances in Infectious Diseases, 2012, 2, 76-81 http://dx.doi.org/10.4236/aid.2012.23012 Published Online September 2012 (http://www.SciRP.org/journal/aid) Mucormycosis: A Review on Environmental Fungal Spores and Seasonal Variation of Human Disease Rima I. El-Herte, Tania A. Baban, Souha S. Kanj* Division of Infectious Diseases, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. Email: *[email protected] Received May 1st, 2012; revised June 3rd, 2012; accepted July 5th, 2012 ABSTRACT Mucormycosis is on the rise especially among patients with immunosuppressive conditions. There seems to be more cases seen at the end of summer and towards early autumn. Several studies have attempted to look at the seasonal varia- tions of fungal pathogens in variou indoor and outdoor settings. Only two reports, both from the Middle East, have ad- dressed the relationship of mucormycosis in human disease with climate conditions. In this paper we review, the rela- tionship of indoor and outdoor fungal particulates to the weather conditions and the reported seasonal variation of hu- man cases. Keywords: Mucormycosis; Seasonal Variation; Fungal Air Particulate Concentration; Mucor; Rhizopus; Rhinocerebral 1. Introduction bread, decaying fruits, vegetable matters, crop debris, soil, compost piles, animal excreta, and on excavation and con- Mucormycosis refers to infections caused by molds be- struction sites. Sporangiospores are easily aerosolized, and longing to the order of Mucorales. Members of the fam- are readily dispersed throughout the environment making ily Mucoraceae are the most common cause of mucor- inhalation the major mode of transmission. Published data mycosis in humans.
    [Show full text]
  • Detection of Histoplasma DNA from Tissue Blocks by a Specific
    Journal of Fungi Article Detection of Histoplasma DNA from Tissue Blocks by a Specific and a Broad-Range Real-Time PCR: Tools to Elucidate the Epidemiology of Histoplasmosis Dunja Wilmes 1,*, Ilka McCormick-Smith 1, Charlotte Lempp 2 , Ursula Mayer 2 , Arik Bernard Schulze 3 , Dirk Theegarten 4, Sylvia Hartmann 5 and Volker Rickerts 1 1 Reference Laboratory for Cryptococcosis and Uncommon Invasive Fungal Infections, Division for Mycotic and Parasitic Agents and Mycobacteria, Robert Koch Institute, 13353 Berlin, Germany; [email protected] (I.M.-S.); [email protected] (V.R.) 2 Vet Med Labor GmbH, Division of IDEXX Laboratories, 71636 Ludwigsburg, Germany; [email protected] (C.L.); [email protected] (U.M.) 3 Department of Medicine A, Hematology, Oncology and Pulmonary Medicine, University Hospital Muenster, 48149 Muenster, Germany; [email protected] 4 Institute of Pathology, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany; [email protected] 5 Senckenberg Institute for Pathology, Johann Wolfgang Goethe University Frankfurt, 60323 Frankfurt am Main, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-30-187-542-862 Received: 10 November 2020; Accepted: 25 November 2020; Published: 27 November 2020 Abstract: Lack of sensitive diagnostic tests impairs the understanding of the epidemiology of histoplasmosis, a disease whose burden is estimated to be largely underrated. Broad-range PCRs have been applied to identify fungal agents from pathology blocks, but sensitivity is variable. In this study, we compared the results of a specific Histoplasma qPCR (H. qPCR) with the results of a broad-range qPCR (28S qPCR) on formalin-fixed, paraffin-embedded (FFPE) tissue specimens from patients with proven fungal infections (n = 67), histologically suggestive of histoplasmosis (n = 36) and other mycoses (n = 31).
    [Show full text]
  • Therapies for Common Cutaneous Fungal Infections
    MedicineToday 2014; 15(6): 35-47 PEER REVIEWED FEATURE 2 CPD POINTS Therapies for common cutaneous fungal infections KENG-EE THAI MB BS(Hons), BMedSci(Hons), FACD Key points A practical approach to the diagnosis and treatment of common fungal • Fungal infection should infections of the skin and hair is provided. Topical antifungal therapies always be in the differential are effective and usually used as first-line therapy, with oral antifungals diagnosis of any scaly rash. being saved for recalcitrant infections. Treatment should be for several • Topical antifungal agents are typically adequate treatment weeks at least. for simple tinea. • Oral antifungal therapy may inea and yeast infections are among the dermatophytoses (tinea) and yeast infections be required for extensive most common diagnoses found in general and their differential diagnoses and treatments disease, fungal folliculitis and practice and dermatology. Although are then discussed (Table). tinea involving the face, hair- antifungal therapies are effective in these bearing areas, palms and T infections, an accurate diagnosis is required to ANTIFUNGAL THERAPIES soles. avoid misuse of these or other topical agents. Topical antifungal preparations are the most • Tinea should be suspected if Furthermore, subsequent active prevention is commonly prescribed agents for dermatomy- there is unilateral hand just as important as the initial treatment of the coses, with systemic agents being used for dermatitis and rash on both fungal infection. complex, widespread tinea or when topical agents feet – ‘one hand and two feet’ This article provides a practical approach fail for tinea or yeast infections. The pharmacol- involvement. to antifungal therapy for common fungal infec- ogy of the systemic agents is discussed first here.
    [Show full text]